FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS

Results of HOPE trial are analyzed. It is noted, that treatment with angiotensine converting enzyme inhibitor (iACE) ramipril improves the prognosis in high risk cardio-vascular patients. The objectives and study design of ONTARGET/TRANSCEND trials are introduced. Perspectives of joint use of ACE in...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsman: Yu. M. Lopatin
Materialtyp: Artigo
Språk:Inglês
Publicerad: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Serie:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Ämnen:
high cardio-vascular risk
ramipril
telmisartan
норе trial
ontarget trial
Länkar:https://www.rpcardio.com/jour/article/view/1052
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk